N. Fiotti et al., Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease, ATHEROSCLER, 145(1), 1999, pp. 51-60
Citations number
48
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Inflammatory phenomena at sites of atherosclerotic plaques are increasingly
thought to be major determinants of the progression and clinical outcome o
f atherosclerotic disease. Therefore, attention is being paid to systemic m
arkers/mediators which may reflect the inflammatory activity in the plaques
. This study evaluates the pattern of the main proinflammatory cytokines tu
mor necrosis factor-alpha (TNF alpha), interleukin-1 beta (IL-1 beta), and
interleukin-6 (IL-6), their soluble receptors/antagonist, and a variety of
inflammatory markers, in patients with peripheral arterial disease (PAD). E
ight patients with PAD suffering from claudicatio intermittens (CI), eight
with critical limb ischemia (CLI) and eight controls (C) were studied. Bloo
d samples were collected at baseline in all groups and, for C and CI, immed
iately after and 4 h after a 30-min treadmill test. Baseline: no difference
s in cytokine plasma levels were detected among the three groups. In contra
st, soluble receptors of TNF (type I and II) and of IL-6, and IL-1 beta rec
eptor antagonist (IL-1ra) were increased in CI and CLI patients, as compare
d to C. Of note, IL-1ra correlated with the occurrence and stage of the dis
ease in a highly significant proportion of the patients, reaching a predict
ive value for the disease of P < 0.0001. The opposite trend was observed fo
r the soluble receptor of IL-1 beta. Notably, in the patients no alteration
s could be found in white blood cell counts, expression of CD11c adherence
molecule by circulating monocytes or, in vitro, O-2(-) release from zymosan
-activated neutrophils. Moreover, plasma levels of platelet activating fact
or (PAF), of neutrophil elastase and of the acute phase reactants C-reactiv
e protein (CRP) and alpha 1-acid glycoprotein were not found to be signific
antly altered. In contrast, the acute-phase proteins ctl-antitrypsin (alpha
1AT) and haptoglobin (HG) were found to be increased. Effect of treadmill:
IL-IP and TNFa remained at baseline levels following exercise, and IL-6 dr
opped to undetectable levels. Among cytokine antagonists, again the most re
levant changes concerned the IL-1ra, which was significantly increased imme
diately after the treadmill test, both in CI and C, and returned to baselin
e levels after 4 h. In contrast, soluble TNF alpha, IL-1 beta and IL-6 rece
ptors, PAF, and the other markers of leukocyte activation were not found to
be altered. Soluble TNF alpha and IL-6 receptors were shown to inhibit the
biological effects of their ligands. Similarly, IL-1ra and the acute phase
proteins alpha 1AT and HG have been reported to exert anti-inflammatory fu
nctions. The increased plasma levels of these agents, together with low lev
els of inflammatory cytokines and other pro-inflammatory mediators such as
PAF and al-acid glycoprotein, appear to draw an undescribed picture, so far
, of upregulation of a composite systemic anti-inflammatory mechanism in at
herosclerotic patients. IL-1ra appears to be a reliable marker of the state
of activation of this mechanism. These results may provide a basis for dev
eloping new insights into the pathogenesis of the atherosclerotic disease.
(C) 1999 Elsevier Science Ireland Ltd. All rights reserved.